Guess the next CR date competition, page-20

My guess is that there will be a signifcant transaction occur before the need for a CR arises. That is also my hope

My reasoning is:
- We are funded through to 2024 already for current plans.
- Management appear reluctant to stretch their resources much beyond the advertised program of trials, etc already planned or underway
- Dr.T has hinted he may continue topping up to reach 10% ownership. I doubt he would wish to be diluted down from that number, and to maintain his % ownership would require a deep dig into his pockets.
- There is a good chance that a partnership may eventuate that provides RAC with payments and/or funding for additional trials
- Management are focused on the end game of a transaction and a CR would imply that the timeline for a transaction would be further extended

Ofcourse, something out of the blue might surprise us, eg
- a deal with BP to take an equity position as part of a staged buyout contigent upon milestones being achieved
- the trials taking longer or are more expensive to complete, hence more money needed
- a 3rd once in a lifetime opportunity, that is too good to ignore (eg new molecule from pillar 3)

Anyway, just my thoughts, please read your own tea leaves. Good luck in your investing !